(Q39246280)

10 September 2017

1 reference

title

Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure (English)

1 reference

10 September 2017

Feinfeld DA

1

1 reference

10 September 2017

Sherwood LM

series ordinal

2

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 June 1988

1 reference

10 September 2017

1 reference

10 September 2017

volume

33

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

1049-1058

1 reference

The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Hyperparathyroidism and renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Parathyroid hormone plasma level in untreated chronic renal failure and in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Calcium, Phosphorus, and Bone in Renal Disease and Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Phosphorus excretion in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The control of phosphate excretion in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Control of phosphate excretion in uremic man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The Phosphaturic Action of PTH in the Steady State in Patients with Normal and Impaired Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Regulation of Parathyroid Hormone Secretion: Proportional Control by Calcium, Lack of Effect of Phosphate1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Bone and soft tissue changes with oral phosphate supplements

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The role of phosphate in the secretion of parathyroid hormone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Evaluation by Radioimmunoassay of Factors Controlling the Secretion of Parathyroid Hormone: Intravenous Infusions of Calcium and Ethylenediamine Tetraacetic Acid in the Cow and Goat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the "trade-off hypothesis".

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Vitamin D: mode of action and biomedical applications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Vitamin D metabolites and their relationship to azotaemic osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Chronic renal failure and vitamin d metabolites: A status report

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Skeletal Resistance to Endogenous Parathyroid Hormone in Patients with Early Renal Failure. A Possible Cause for Secondary Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

TUBULAR REABSORPTION OF PHOSPHATE IN PRIMARY HYPERPARATHYROIDISM--BEFORE AND AFTER ADMINISTRATION OF PARATHYROID HORMONE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Extraction of parathyroid hormone and release of adenosine 3',5'-monophosphate by isolated perfused bones obtained from dogs with acute uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Down-regulation of parathyroid hormone (PTH) receptors in cultured bone cells is associated with agonist-specific intracellular processing of PTH-receptor complexes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Acute Actions of 1, 25-Dihydroxy-Vitamin D3in Normal Man:Effect on Calcium and Parathyroid Status

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Effects of magnesium on parathyroid hormone secretion during chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Determinants of serum 1,25(OH)2D levels in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Circulating vitamin D metabolite concentrations in childhood renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Unilateral nephrectomy and 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Steroid hormone action in eucaryotic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Vitamin D receptors: nature and function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Inhibition by 1,25 dihydroxycholecalciferol of hormonal secretion of rat parathyroid gland in organ culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Vitamin D, parathyroid hormone, and renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

The interaction of parathyroid hormone and aluminum in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Hyperaluminaemia from aluminum resins in renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Suppression of parathyroid hormone secretion by aluminum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Aluminum action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Impaired Parathyroid Hormone Metabolism in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Effects of long-term therapy with calcitriol in patients with moderate renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for pre-proparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.110

7 January 2021

Identifiers

DOI

10.1038/KI.1988.110

1 reference

10 September 2017

1 reference